- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 231/24 - SeparationPurification
Patent holdings for IPC class C07C 231/24
Total number of patents in this class: 275
10-year publication summary
15
|
22
|
17
|
14
|
17
|
30
|
17
|
14
|
14
|
14
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
GE Healthcare AS | 224 |
21 |
Showa Denko K.K. | 2196 |
8 |
Tate & Lyle Technology Limited | 216 |
7 |
BASF SE | 21017 |
6 |
Resonac Corporation | 2917 |
6 |
Les Laboratoires Servier | 536 |
5 |
Newron Pharmaceuticals S.p.A. | 62 |
5 |
Zhejiang Huahai Pharmaceutical Co., Ltd. | 208 |
5 |
Supercritical Fluid Technologies, Inc. | 16 |
5 |
Mitsubishi Chemical Corporation | 4579 |
4 |
Teva Pharmaceutical Industries Ltd. | 773 |
4 |
Teva Pharmaceuticals USA, Inc. | 869 |
4 |
Novo Nordisk A/S | 2281 |
4 |
Anhui Jinhe Industrial Co., Ltd. | 89 |
3 |
Crystal PharmaTech Co., Ltd | 84 |
3 |
Geron Corporation | 166 |
3 |
Instituto Superior Tecnico | 152 |
3 |
Paratek Pharmaceuticals, Inc. | 112 |
3 |
Shanghai Institute of Pharmaceutical Industry | 129 |
3 |
UPL Limited | 594 |
3 |
Other owners | 170 |